Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors

Conditions: Advanced Solid Tumors Interventions: Biological: MK-1200; Drug: Antiemetic Sponsors: Merck Sharp& Dohme LLC Not yet recruiting

Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials